Comments
Loading...

Quest Diagnostics

DGXNYSE
Logo brought to you by Benzinga Data
$155.94
0.460.30%
Last update: 10:37 AM
15 minutes delayed
Consensus Rating1
Neutral
Highest Price Target1
$170.00
Lowest Price Target1
$135.00
Consensus Price Target1
$151.41

Quest Diagnostics (NYSE:DGX) Stock, Analyst Ratings, Price Targets, Forecasts

Quest Diagnostics Inc has a consensus price target of $151.41 based on the ratings of 22 analysts. The high is $170 issued by Keybanc on December 13, 2021. The low is $135 issued by Leerink Partners on February 26, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Barclays, and Piper Sandler on August 28, 2024, August 27, 2024, and July 29, 2024, respectively. With an average price target of $156.33 between Evercore ISI Group, Barclays, and Piper Sandler, there's an implied 0.25% upside for Quest Diagnostics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
3
Apr
1
May
3
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.2
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Evercore ISI Group
Barclays
Piper Sandler
Baird
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Quest Diagnostics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Quest Diagnostics (DGX) stock?

A

The latest price target for Quest Diagnostics (NYSE:DGX) was reported by Evercore ISI Group on August 28, 2024. The analyst firm set a price target for $165.00 expecting DGX to rise to within 12 months (a possible 5.81% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Quest Diagnostics (DGX)?

A

The latest analyst rating for Quest Diagnostics (NYSE:DGX) was provided by Evercore ISI Group, and Quest Diagnostics their in-line rating.

Q

When was the last upgrade for Quest Diagnostics (DGX)?

A

The last upgrade for Quest Diagnostics Inc happened on July 10, 2024 when Citigroup raised their price target to $165. Citigroup previously had a neutral for Quest Diagnostics Inc.

Q

When was the last downgrade for Quest Diagnostics (DGX)?

A

The last downgrade for Quest Diagnostics Inc happened on May 2, 2023 when B of A Securities changed their price target from $166 to $148 for Quest Diagnostics Inc.

Q

When is the next analyst rating going to be posted or updated for Quest Diagnostics (DGX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quest Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quest Diagnostics was filed on August 28, 2024 so you should expect the next rating to be made available sometime around August 28, 2025.

Q

Is the Analyst Rating Quest Diagnostics (DGX) correct?

A

While ratings are subjective and will change, the latest Quest Diagnostics (DGX) rating was a with a price target of $0.00 to $165.00. The current price Quest Diagnostics (DGX) is trading at is $155.94, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch